MKC vs OKUR · P/E 8.4, rev $3.81B vs P/E 72, rev $2.0M
McCormick & Company Incorporated (MKC) versus OnKure Therapeutics, Inc. (OKUR) — a side-by-side from cached financials, not a winner call.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
Latest reported MKC revenue for 2026-05-31 was $3.81B. Net income was $1.17B. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Latest reported OKUR revenue for 2026-06-30 was $2.0M. Net income was -$30.5M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
MKC currently screens at market cap $13.56B and trailing P/E 8.4. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Not investment advice. Open the MKC and OKUR stock pages for the full models.
Not investment advice.